All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-23762404
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 23762404 T4228C
NCR2
Uterine Cervical Neoplasms
G
C
View
2 23762404 A1842G
E1
E1
Uterine Cervical Neoplasms
G
C
View
3 23762404 A479A
E1
E1
Uterine Cervical Neoplasms
G
C
View
4 23762404 C2344T
E1
E1
Uterine Cervical Neoplasms
G
C
View
5 23762404 C874T
E1
E1
Uterine Cervical Neoplasms
G
C
View
6 23762404 D352D
E1
E1
Uterine Cervical Neoplasms
G
C
View
7 23762404 D352E
E1
E1
Uterine Cervical Neoplasms
G
C
View
8 23762404 E596K
E1
E1
Uterine Cervical Neoplasms
G
C
View
9 23762404 F19F
E1
E1
Uterine Cervical Neoplasms
G
C
View
10 23762404 F493F
E1
E1
Uterine Cervical Neoplasms
G
C
View
11 23762404 F638F
E1
E1
Uterine Cervical Neoplasms
G
C
View
12 23762404 G1293T
E1
E1
Uterine Cervical Neoplasms
G
C
View
13 23762404 G1363A
E1
E1
Uterine Cervical Neoplasms
G
C
View
14 23762404 G167S
E1
E1
Uterine Cervical Neoplasms
G
C
View
15 23762404 G1941A
E1
E1
Uterine Cervical Neoplasms
G
C
View
16 23762404 G2337A
E1
E1
Uterine Cervical Neoplasms
G
C
View
17 23762404 G2650A
E1
E1
Uterine Cervical Neoplasms
G
C
View
18 23762404 I186T
E1
E1
Uterine Cervical Neoplasms
G
C
View
19 23762404 I194I
E1
E1
Uterine Cervical Neoplasms
G
C
View
20 23762404 I326M
E1
E1
Uterine Cervical Neoplasms
G
C
View
21 23762404 L145I
E1
E1
Uterine Cervical Neoplasms
G
C
View
22 23762404 L494L
E1
E1
Uterine Cervical Neoplasms
G
C
View
23 23762404 L536L
E1
E1
Uterine Cervical Neoplasms
G
C
View
24 23762404 M491I
E1
E1
Uterine Cervical Neoplasms
G
C
View
25 23762404 N538N
E1
E1
Uterine Cervical Neoplasms
G
C
View
26 23762404 P4S
E1
E1
Uterine Cervical Neoplasms
G
C
View
27 23762404 Q143H
E1
E1
Uterine Cervical Neoplasms
G
C
View
28 23762404 Q359Q
E1
E1
Uterine Cervical Neoplasms
G
C
View
29 23762404 S119S
E1
E1
Uterine Cervical Neoplasms
G
C
View
30 23762404 T1221C
E1
E1
Uterine Cervical Neoplasms
G
C
View
31 23762404 T1297A
E1
E1
Uterine Cervical Neoplasms
G
C
View
32 23762404 T1421C
E1
E1
Uterine Cervical Neoplasms
G
C
View
33 23762404 T1446C
E1
E1
Uterine Cervical Neoplasms
G
C
View
34 23762404 T1920C
E1
E1
Uterine Cervical Neoplasms
G
C
View
35 23762404 T1920G
E1
E1
Uterine Cervical Neoplasms
G
C
View
36 23762404 T2301C
E1
E1
Uterine Cervical Neoplasms
G
C
View
37 23762404 T2343C
E1
E1
Uterine Cervical Neoplasms
G
C
View
38 23762404 T2470C
E1
E1
Uterine Cervical Neoplasms
G
C
View
39 23762404 T2478C
E1
E1
Uterine Cervical Neoplasms
G
C
View
40 23762404 T2778C
E1
E1
Uterine Cervical Neoplasms
G
C
View
41 23762404 T921C
E1
E1
Uterine Cervical Neoplasms
G
C
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.